|
N=20 |
N=20 |
N=20 |
N=20 |
N=20 |
N=20 |
N=20 |
N=20 |
|
n(%) |
Incidence |
n(%) |
Incidence |
n(%) |
Incidence |
n(%) |
Incidence |
Any treatment-emergent adverse event |
6 (30.0%) |
9 |
1 ( 5.0%) |
1 |
5 (25.0%) |
6 |
9 (45.0%) |
16 |
Gamma-glutamyl transferase increased |
0 |
0 |
0 |
0 |
1 ( 5.0%) |
1 |
1 ( 5.0%) |
1 |
Alanine aminotransferase increased |
2 (10.0%) |
2 |
0 |
0 |
0 |
0 |
2
(10.0%) |
2 |
White blood cells urine positive |
1 ( 5.0%) |
1 |
0 |
0 |
0 |
0 |
1 (
5.0%) |
1 |
Glucose urine present |
1 ( 5.0%) |
1 |
0 |
0 |
0 |
0 |
1 ( 5.0%) |
1 |
Basophil Count increased |
1 ( 5.0%) |
1 |
0 |
0 |
1 ( 5.0%) |
1 |
1 (
5.0%) |
2 |
Heart rate increased |
1 ( 5.0%) |
1 |
0 |
0 |
1 ( 5.0%) |
1 |
2
(10.0%) |
2 |
Blood triglycerides increased |
2 (10.0%) |
2 |
0 |
0 |
0 |
0 |
2
(10.0%) |
2 |
Blood glucose increased |
1 ( 5.0%) |
1 |
0 |
0 |
0 |
0 |
1 ( 5.0%) |
1 |
Blood pressure decreased |
0 |
0 |
1 ( 5.0%) |
1 |
2 (10.0%) |
3 |
2
(10.0%) |
4 |